Agilent Technologies Soars 9.29% on Q4 Earnings Beat, 15% Segment Growth Drive Analyst Optimism

The share price of Agilent Technologies (A) rose to its highest level so far this month, with an intraday gain of 4.34% on Nov. 26. The stock has now climbed 9.29% over the past five trading days, extending a five-day winning streak.

The surge follows strong fourth-quarter results, including adjusted earnings per share of $1.59, exceeding estimates, and revenue of $1.86 billion. The company’s Life Sciences and Diagnostics segment drove growth with a 15% year-over-year increase. Analysts at Leerink Partners and BofA Securities raised price targets to $165, citing confidence in sustained demand and margin expansion from initiatives like the Ignite Operating System.

Despite a P/E ratio of 35.62, which exceeds fair value estimates, institutional analysts remain optimistic. Agilent’s guidance for FY2026, projecting revenue of $7.3–7.4 billion and adjusted EPS of $5.86–$6.00, underscores its market position. However, risks include valuation concerns and macroeconomic uncertainties, though management is confident in mitigating tariffs and maintaining operational efficiency.